All Episodes

GLP1 Improving Heart Health

Rapid evolution of GLP-1: A Comprehensive Update

Ethics and Accessibility of GLP-1ra Long Term

What This 2024 Presidential Election Means for GLP-1ra and Big Pharma

GLP1s - a deeper dive into how they work

Current trends in weight loss: What's going on? What's the big picture?

FDA reverses decision to halt compounding of Terzepetide, for now

Big Pharma Grilled on GLP1 Pricing; Why are Ozempic and other drugs so expensive?

Novo Nordisk pushes FDA to stop GLP1 compounding citing "complexity'

featured sponsor episode: tune-health

FDA warnings about adverse reactions to GLP1s due to common errors

GLP1 and its positive benefit in reducing addictions

GLP1 Week in Review (10-20-2024)

Common Mistakes People Make on GLP1 Protocols

What Goes Into Manufacturing GLP-1

Effectiveness of Compounded Semaglutide

Insurance Coverage for Weight Loss Meds: Challenges & Opportunities

Successfully Fighting for Insurance Coverage & Major Insurers Covering GLP1

Denied Insurance Coverage? Steps you can take.

Weight Loss Drugs & Employer Coverage

Week In Review: GLP-1 in the News (October 12, 2024)

Plant Based Diets and GLP1s

Neuroplasticity and GLP1s

Neuroprotective Effects of GLP1ra and Glaucoma

Weight Loss & Fertility

Sarcopenic Obesity

The Battle in Pharma: The Heavyweights vs. The Online Retailers

Navigating Insurance Coverage

Changing Tastes & Preferences

Managing Metabolic Syndrome

Adjusting to the Medications

A Tale of Supply and Demand

Fatty Liver Disease

Emotional Eating and GLP-1ra

GLP1 Lowering Cholesterol Levels

GLP1ra Gut Microbiome

GLP1ra Food Cravings

GLP1ra Review of the Clinical Trials

GLP1ra Success Stories & Benefits

GLP1ra Side Effects

GLP-1ra Who is an Ideal Candidate?

GLP1ra vs Traditional Weight Loss

The History of GLP-ra Medications